טוען...
Cancer Immunotherapy Using Checkpoint Blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses in patients with a variety of cancers. This can be achieved by antibodies blocking the cytotoxic T lymphocyte antigen-4 (CTL...
שמור ב:
| הוצא לאור ב: | Science |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7391259/ https://ncbi.nlm.nih.gov/pubmed/29567705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aar4060 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|